Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADGI | AMGN | VRTX | REGN | BMY |
| Company | Adagio Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.62 | 334.56 | 493.14 | 1,067.54 | 48.27 |
| High | 4.74 | 338.94 | 502.97 | 1,091.31 | 50.61 |
| Low | 4.40 | 333.28 | 492.17 | 1,067.54 | 47.73 |
| Last | 4.64 | 334.85 | 495.26 | 1,078.63 | 50.45 |
| Change | +0.04 | +0.55 | +3.00 | +14.44 | +5.18 |
| % Change | +0.87% | +0.16% | +0.61% | +1.36% | +11.44% |
| Volume | 536,300 | 1,515,400 | 774,100 | 380,800 | 36,636,400 |
| 20-Day Average Volume | 740,320 | 1,897,160 | 1,086,435 | 405,595 | 17,120,881 |
| Previous Close | 4.60 | 334.30 | 492.26 | 1,064.19 | 45.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.47 | 324.73 | 485.57 | 1,064.57 | 42.09 |
| 20-Day Raw Stochastic | 77.39% | 70.54% | 77.01% | 70.86% | 98.58% |
| 20-Day Relative Strength | 58.02% | 65.60% | 65.12% | 59.08% | 75.30% |
| Weighted Alpha | -67.60 | +41.43 | +44.06 | +43.97 | -12.01 |
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 16% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.93% since 09/02/22 | +1.07% since 07/19/24 | +0.75% since 07/19/24 | +1.41% since 07/19/24 | +18.32% since 07/19/24 |
| Low | 4.40 on 09/12/22 | 330.34 on 07/24/24 | 486.25 on 07/24/24 | 1,052.81 on 07/24/24 | 41.90 on 07/23/24 |
| High | 4.82 on 09/07/22 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,102.95 on 07/25/24 | 50.61 on 07/26/24 |
| 1-Month | |||||
| %Chg | +16.29% since 08/12/22 | +7.04% since 06/26/24 | +4.49% since 06/26/24 | +0.89% since 06/26/24 | +18.71% since 06/26/24 |
| Low | 3.75 on 08/16/22 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 39.35 on 07/05/24 |
| High | 4.90 on 08/22/22 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 50.61 on 07/26/24 |
| 3-Month | |||||
| %Chg | +56.76% since 06/10/22 | +24.03% since 04/26/24 | +24.60% since 04/26/24 | +22.13% since 04/26/24 | +12.49% since 04/26/24 |
| Low | 2.41 on 06/15/22 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 39.35 on 07/05/24 |
| High | 4.90 on 08/22/22 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 50.61 on 07/26/24 |
| 6-Month | |||||
| %Chg | -8.12% since 03/11/22 | +7.40% since 01/26/24 | +15.13% since 01/26/24 | +14.74% since 01/26/24 | +1.51% since 01/26/24 |
| Low | 2.41 on 06/15/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 6.14 on 03/30/22 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 504,976 | 179,625,264 | 127,803,344 | 118,849,912 | 102,267,200 |
| Shares Outstanding, K | 108,831 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -226,790,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -50,990,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | N/A | 0.58 | 0.39 | 0.13 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 08/15/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 09/19/22 | 08/06/24 | 08/01/24 | 08/01/24 | 07/26/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.94 | 32.69 | 28.68 | 43.11 |